1 Volmink J, Matchaba P, Garner P. Directly observed therapy and treat-ment adherence[J]. Lancer, 2000,355:1345-1350
2 Pabloe-Mendez A. Working alliance for TB drug development,Cape Town, South Africa, February 8th, 2000 [J]. Int J Tuberc Lung Dis,2000,4:489-490
3 Ashokraj Y, Ayrawal S, Varma MV, et al. Quality control of anti-tu-berculosis fixed-does combination formulations in global maket :An in Vitro stady [J].lniernational Journal of Tuberculosis and lung Disease 2004,8(9):1081-1088
4 赵伟杰,李惠文,段连山,等.国产抗结核固定剂量复合剂的药效学和药代动力学研究[J].中华结核和呼吸杂志,2002,25:333-336
5 Fox W. Drug combinations and the bioavailbility of rifampicin[J].Tubercle,1990,71(4):241-245